Yvette Venable | Global Director of Payer Partnerships and Policy
AstraZeneca

Yvette Venable Global Director Payer Partnerships and Policy Global Market Access & Pricing, Biopharma Business Unit, AstraZeneca   Ms. Venable is an accomplished life sciences leader, with more than 25 years’ experience in health policy, patient advocacy, and patient access. Currently, she leads global payer policy for AstraZeneca’s Biopharmaceutical Business Unit. Previously, Ms. Venable was the first vice president of patient and community engagement for the Institute of Clinical and Economic Review (ICER), a non-profit Health Technology Assessor in the U.S.A. She also previously led global and European public policy and patient advocacy functions within life sciences companies across a range of serious conditions including cancer, hepatitis, asthma, RA, diabetes and rare and ultra-rare conditions. Earlier in her career, Yvette held increasingly senior roles within global health communication and public affairs consultancies. Ms. Venable graduated with honors from Drake University in Des Moines, Iowa, and holds a Masters of Global Public Health at Imperial College London.